1887

Journal of General Virology header logo

Volume 71, Issue 11

Identification of seroreactive regions of the human papillomavirus type 16 proteins E4, E6, E7 and L1 Free

Abstract

Small fragments of the DNA of human papillomavirus type 16 (HPV-16) were randomly cloned into the bacteriophage fd which expresses the resulting peptides as part of its capsid. Antisera raised against different HPV-16 fusion proteins were used for screening of the phage clones and the reacting peptides were determined by sequencing the inserted HPV-16 DNA fragments of the positive recombinants. Seroreactive regions of the proteins derived from the E4, E6, E7 (two regions) and LI (three regions) open reading frames could be found by this approach. Of these seven regions, four were defined by at least two overlapping inserts, thus limiting the domains to between 10 and 15 amino acids. In the case of the E4 open reading frame, the same region identified by immunoscreening was also found when synthetic overlapping octapeptides were tested by ELISA with the anti-E4 antiserum. Using an approach to predict ‘receptor-like’ regions within the respective proteins, five of the seven regions were also identified. From the data on these regions, synthetic peptides were produced and used for the detection of antibodies against HPV-16 proteins in human sera by ELISA.

  • Received:
  • Accepted:
  • Published Online:
© Society for General Microbiology 1990
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-71-11-2709
1990-11-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/71/11/JV0710112709.html?itemId=/content/journal/jgv/10.1099/0022-1317-71-11-2709&mimeType=html&fmt=ahah

References

  1. Brasseur R. 1988; Calculation of the three dimensional structure of Saccharomyces cerevisiae cytochrome b inserted in a lipid matrix. Journal of Biological Chemistry 263:12571–12575
     [Google Scholar]
  2. Brasseur R., Cornet B., Burny A., Vandenbranden M., Ruysschaert J. M. 1988; Mode of insertion into lipid membrane of the N-terminal HIV gp41 peptide segment. AIDS Research and Human Retroviruses 4:83–90
     [Google Scholar]
  3. Cason J., Patel D., Naylor J., Lunney D., Shepherd P. S., Best J. M., Mccance D. J. 1989; Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes. Journal of General Virology 70:2973–2987
     [Google Scholar]
  4. Castro B., Domroy B.R., Evin G., Selve C. 1975; Reactifs de couplage peptidique IV(1)-L’hexafluorophosphate de benzotriazolyl N-oxytrisdimethylamino phosphonium (B.O.P.). Tetrahedron Letters 14:1219–1222
     [Google Scholar]
  5. Cerami A., Beutler B. 1986; Cachetin and tumour necrosis factor as two sides of the same biological coin. Nature; London: 320584–588
     [Google Scholar]
  6. de Loof H., Rosseneu M., Brasseur R., Ruysschaert J. M. 1986; Use of hydrophobicity profiles to predict receptor binding domains on apolipoprotein E and the low density lipoprotein apolipoprotein B-E receptor. Proceedings of the National Academy of Sciences, U.S.A 83:2295–2299
     [Google Scholar]
  7. de Villiers E. M., Wagner D., Schneider A., Wesch H., Miklaw H., Wahrendorf J., Papendick U., zur Hausen H. 1987; Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet ii:703–706
     [Google Scholar]
  8. Dillner J., Dillner L., Utter G., Eklund G., Rotola A., Costa S., Diluca D. 1990; Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames. International Journal of Cancer 45:529–535
     [Google Scholar]
  9. Doorbar J., Campbell D., Grand R. J. A., Gallimore P. 1986; Identification of the human papillomavirus-1a E4 gene products. EMBO Journal 5:355–362
     [Google Scholar]
  10. Dyson N., Howley P. M., Münger K., Harlow E. 1989; The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934–937
     [Google Scholar]
  11. Eisenberg D. 1984; Three-dimensional structure of membrane and surface proteins. Annual Review of Biochemistry 53:595–623
     [Google Scholar]
  12. Eisenberg D., Weiss T. C., Williger J. 1982; The helical hydrophobic moment : a measure of the amphiphilicity of a helix. Nature; London: 200371–374
     [Google Scholar]
  13. Eisenberg D., Schwarz E., Komaomy M., Wall R. 1984; Analysis of membrane and surface protein sequences with the hydrophobic moment plot. Journal of Molecular Biology 179:125–142
     [Google Scholar]
  14. Garnier J., Osguthorpe L., Robson B. 1987; Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. Journal of Molecular Biology 120:97–120
     [Google Scholar]
  15. Geysen H. M., Meloen R. H., Barteling S. J. 1984; Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proceedings of the National Academy of Sciences, U.S.A 81:3998–4002
     [Google Scholar]
  16. Geysen H. M., Barteling S. J., Meloen R. H. 1985; Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the same protein. Proceedings of the National Academy of Sciences, U.S.A 82:178–182
     [Google Scholar]
  17. Hanahan D. 1983; Studies on transformation of Escherichia coli with plasmids. Journal of Molecular Biology 166:557–580
     [Google Scholar]
  18. Holland V. R., Saunders B. C., Rose F. L., Walpole A. L. 1974; A safer substitute for benzidine in the detection of blood. Tetrahedron 30:3299–3302
     [Google Scholar]
  19. Jochmus-Kudielka I., Gissmann L. 1990; Expression of human papillomavirus type 16 proteins in Escherichia coli and their use as antigens in serological tests. In Recombinant Systems in Protein Expression pp. 87–93 Alitalo K. K., Hutala M. L., Knowles J., Vaheri A. Edited by Amsterdam: Elsevier;
     [Google Scholar]
  20. Jochmus-Kudielka I., Schneider A., Braun R., Kimmig R., Koldovsky U., Schneweis K.-E., Seedorf K., Gissmann L. 1989; Antibodies against human papillomavirus type 16 early proteins in human sera: anti E7 reactivity correlates with cervical cancer. Journal of the National Cancer Institute 81:1698–1704
     [Google Scholar]
  21. Lyons L. B., Zinder N. D. 1972; The genetic map of the filamentous bacteriophage f1. Virology 49:45–60
     [Google Scholar]
  22. Müller M., Jochmus-Kudielka I., Gausepohl H., Frank R., Gissmann L. 1990; Detection of antibodies against early proteins of human papillomavirus type 16 in human sera. In Oncogenes in Cancer Diagnostics, Contributions in Oncology 39 Munk K. Edited by Basel: Karger; in press
    [Google Scholar]
  23. Münger K., Phelps W. C., Bubb V., Howley P. M., Schlegel R. 1989; The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. Journal of Virology 63:4417–4421
     [Google Scholar]
  24. Oltersdorf T., Seedorf K., Röwekamp W., Gissmann L. 1987; Identification of human papillomavirus type 16 E7 protein by monoclonal antibodies. Journal of General Virology 68:2933–2938
     [Google Scholar]
  25. Parmley S. F., Smith G. P. 1988; Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene 7:305–318
     [Google Scholar]
  26. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual, 2nd edn. New York: Cold Spring Harbor Laboratory;
     [Google Scholar]
  27. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, U.S.A 74:5463–5467
     [Google Scholar]
  28. Schneider A., Hotz M., Gissmann L. 1987; Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. International Journal of Cancer 40:198–201
     [Google Scholar]
  29. Schwarz E., Freese U. K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. 1985; Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature; London: 314111–114
     [Google Scholar]
  30. Seedorf K., Krämmer G., Dürst M., Suhai S., Röwekamp W. 1985; Human papillomavirus type 16 DNA sequence. Virology 145:181–185
     [Google Scholar]
  31. Smith G. P. 1985; Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228:1315–1317
     [Google Scholar]
  32. Tindle R. W., Smith J. A., Geysen H. M., Selvey L. A., Frazer I. H. 1990; Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein. Journal of General Virology 71:1347–1354
     [Google Scholar]
  33. Wood W. B. 1966; Host specificity of DNA produced by Escherichia coli: bacterial mutations affecting the restriction and modification of DNA. Journal of Molecular Biology 16:118–133
     [Google Scholar]
  34. Zacher A. N., Stock C. A., Golden J. W., Smith G. P. 1980; A new filamentous phage cloning vector: fd-tet. Gene 9:127–140
     [Google Scholar]
  35. zur Hausen H. 1989; Papillomaviruses as carcinomaviruses. In Advances in Viral Oncology 8 pp. 1–26 Klein G. Edited by New York: Raven Press;
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-71-11-2709
Loading
Identification of seroreactive regions of the human papillomavirus type 16 proteins E4, E6, E7 and L1
J. Gen. Virol. 71, 2709 (1990); https://doi.org/10.1099/0022-1317-71-11-2709
/content/journal/jgv/10.1099/0022-1317-71-11-2709
/content/journal/jgv/10.1099/0022-1317-71-11-2709
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error